Active Ingredient: MACITENTAN; TADALAFIL
Proprietary Name: OPSYNVI
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 10MG;40MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N218490
Product Number: 002
Approval Date: Mar 22, 2024
Applicant Holder Full Name: ACTELION PHARMACEUTICALS US INC
Marketing Status:
Prescription
Patent and Exclusivity Information